#imids risultati di ricerca

[…]Pregnancy should be a time of joy; however, for many patients with chronic diseases, this can be obscured by feelings of apprehension […]We must empower women on their reproductive journey-being told to avoid pregnancy altogether must be a thing of the past. #IMIDS

Editorial reciente sobre embarazo 🤰🏻 y enfermedades reumáticas. Acceso abierto 🔑 thelancet.com/pdfs/journals/…



📱 ‘@biogen lanza la app 'Care+' para pacientes con enfermedades inflamatorias inmunomediadas.’ . ℹ️ bit.ly/3XcMWrC @DiarioSigloXXI . 📷: @NordWoodThemes #careplus #IMIDs #crohn #colitisulcerosa #EII @VitalFundazioa @Araba @vitoriagasteiz @ACCU_Espana @GETEII

AccuAlava's tweet image. 📱 ‘@biogen lanza la app 'Care+' para pacientes con enfermedades inflamatorias inmunomediadas.’ 
.
ℹ️  bit.ly/3XcMWrC  @DiarioSigloXXI
.
📷:  @NordWoodThemes #careplus #IMIDs #crohn #colitisulcerosa #EII @VitalFundazioa @Araba @vitoriagasteiz @ACCU_Espana @GETEII

Stuart Conway @conway_group about a bump-and-hole approach based on #IMiDs and IKZF1/3. Broad potential application space in chemical biology, target validation but also as switch for therapeutic biomacromolecules such as CAR-T cells. #EFMCISMC24 @EuroMedChem

HartungIngo's tweet image. Stuart Conway @conway_group about a bump-and-hole approach based on #IMiDs and IKZF1/3. Broad potential application space in chemical biology, target validation but also as switch for therapeutic biomacromolecules such as CAR-T cells. #EFMCISMC24 @EuroMedChem
HartungIngo's tweet image. Stuart Conway @conway_group about a bump-and-hole approach based on #IMiDs and IKZF1/3. Broad potential application space in chemical biology, target validation but also as switch for therapeutic biomacromolecules such as CAR-T cells. #EFMCISMC24 @EuroMedChem
HartungIngo's tweet image. Stuart Conway @conway_group about a bump-and-hole approach based on #IMiDs and IKZF1/3. Broad potential application space in chemical biology, target validation but also as switch for therapeutic biomacromolecules such as CAR-T cells. #EFMCISMC24 @EuroMedChem
HartungIngo's tweet image. Stuart Conway @conway_group about a bump-and-hole approach based on #IMiDs and IKZF1/3. Broad potential application space in chemical biology, target validation but also as switch for therapeutic biomacromolecules such as CAR-T cells. #EFMCISMC24 @EuroMedChem

Dejemos de mirar hacia otro lado: MÁS del 10% de pacientes con enfermedades inmunomediadas, #IMIDs, cumplen criterios de #Fibromialgia ¿La tratamos adecuadamente?

Cross-sectional study of 50 SLE patients, 24% had fibromyalgianess, and 18% experienced widespread pain. Fibromyalgianess in SLE patients primarily reflects heightened pain sensitivity and symptom severity rather than SLE disease activity. buff.ly/4jzNxQG

RheumNow's tweet image. Cross-sectional study of 50 SLE patients,  24% had fibromyalgianess, and 18% experienced widespread pain.  Fibromyalgianess in SLE patients primarily reflects heightened pain sensitivity and symptom severity rather than SLE disease activity. buff.ly/4jzNxQG


I’m excited to share that I’m starting a new position as Assistant Professor and Consultant in Clinical Immunology at University of Pisa #Italy. I will continue to collaborate with @unibirmingham and @UniofOxford to investigate the mechanisms of inflammation in #IMIDs @Unipisa


Join us on June 08, 2024 for Multidisciplinary Care in IBD @MCIBD_Can for an interactive day on the #multidisciplinary approach to managing IBD and #IMIDs in #preconception and #pregnancy, and bringing together practitioners from diverse specialties including gastroenterology,


Happy to share the missing link between the action of #IMiDs & #CELMoDs and the natural #CRBN degron @BBRCME: Neo-substrates mimic every single H-bond of cyclic imide #degron recognition, inevitably inheriting sequence-independence of natural #degrons 👇 sciencedirect.com/science/articl…


Is #biodiversity loss linked to the rise in #IMIDs like #type1diabetes? @MFT_Diabetes @CIM_Sweden @karolinskainst are happy to work on this fascinating project led by @akisink @MarjaRoslund @LukeFinland @helsinkiuni in collaboration with @TampereUni

Production, analysis, and safety assessment of a soil and plant-based natural material with microbiome- and immune-modulatory effects biorxiv.org/cgi/content/sh… #biorxiv_micrbio



🤩 Evento interdisciplinare a Torino gastroenterologia, dermatologia e reumatologia insieme per discutere le ultime novità nella gestione delle #IMIDs. Un confronto stimolante su terapie 💊💉tradizionali e a bersaglio molecolare! #Salute #Medicina #Innovazione #Terapie

Sim_Orizon's tweet image. 🤩 Evento interdisciplinare a Torino gastroenterologia, dermatologia e reumatologia insieme per discutere le ultime novità nella gestione delle #IMIDs. Un confronto stimolante su terapie 💊💉tradizionali e a bersaglio molecolare!
#Salute #Medicina #Innovazione #Terapie
Sim_Orizon's tweet image. 🤩 Evento interdisciplinare a Torino gastroenterologia, dermatologia e reumatologia insieme per discutere le ultime novità nella gestione delle #IMIDs. Un confronto stimolante su terapie 💊💉tradizionali e a bersaglio molecolare!
#Salute #Medicina #Innovazione #Terapie
Sim_Orizon's tweet image. 🤩 Evento interdisciplinare a Torino gastroenterologia, dermatologia e reumatologia insieme per discutere le ultime novità nella gestione delle #IMIDs. Un confronto stimolante su terapie 💊💉tradizionali e a bersaglio molecolare!
#Salute #Medicina #Innovazione #Terapie

𝐕𝐈𝐈𝐈 𝗝𝗼𝗿𝗻𝗮𝗱𝗮 𝗙𝗔𝗥𝗨𝗣𝗘𝗜𝗕: 𝗛𝘂𝗺𝗮𝗻𝗶𝘇𝗮𝗰𝗶𝗼́𝗻 𝘃𝘀 𝗧𝗲𝗰𝗻𝗼𝗹𝗼𝗴𝗶́𝗮 #lazaretofh24 | 📍Menorca Cerramos la sesión de #PerlasClínicas con el último bloque  👩‍⚕️@antonia_maestre modera el bloque de #IMIDs ➡️ Servicio de Farmacia. Hospital de Manacor


🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition #IMIDs #rheumat #gastro #ophthalm #derm link.springer.com/article/10.118…

BMCMedicine's tweet image. 🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition

#IMIDs #rheumat #gastro #ophthalm #derm

link.springer.com/article/10.118…

With over 27,000 views, this special issue presents recent findings using omics technologies to uncover crucial molecular mechanisms underlying chronic immune-mediated inflammatory diseases (IMIDs). Access the free reprint: brnw.ch/21wE71g #mdpi #openaccess #IMIDs

MDPIOpenAccess's tweet image. With over 27,000 views, this special issue presents recent findings using omics technologies to uncover crucial molecular mechanisms underlying chronic immune-mediated inflammatory diseases (IMIDs).

Access the free reprint: brnw.ch/21wE71g

#mdpi #openaccess #IMIDs

My supervisor Prof Stuart Conway will be presenting work from my PhD project on #IMiDs at #ACSFall2023 , excited to see it out in the world! #molecularglues #targetedproteindegradation #bumpandhole #targetvalidation

Looking forward to the @ACS_DivBioChem session on The Intersection of Biological and Medicinal Chemistry at #ACSFall2023. Exciting talks from many others including @rhuanglab, @PrOF_NMR, @FairlieGroup, @PPYlabGT, and @nlatefi. Room 209 Tues 8 am - 12 noon. #medchem #chembiol

conway_group's tweet image. Looking forward to the @ACS_DivBioChem session on The Intersection of Biological and Medicinal Chemistry at #ACSFall2023. Exciting talks from many others including @rhuanglab, @PrOF_NMR, @FairlieGroup, @PPYlabGT, and @nlatefi. Room 209 Tues 8 am - 12 noon. #medchem #chembiol
conway_group's tweet image. Looking forward to the @ACS_DivBioChem session on The Intersection of Biological and Medicinal Chemistry at #ACSFall2023. Exciting talks from many others including @rhuanglab, @PrOF_NMR, @FairlieGroup, @PPYlabGT, and @nlatefi. Room 209 Tues 8 am - 12 noon. #medchem #chembiol
conway_group's tweet image. Looking forward to the @ACS_DivBioChem session on The Intersection of Biological and Medicinal Chemistry at #ACSFall2023. Exciting talks from many others including @rhuanglab, @PrOF_NMR, @FairlieGroup, @PPYlabGT, and @nlatefi. Room 209 Tues 8 am - 12 noon. #medchem #chembiol


👇 The full impact ( bidirectional - ‘positive or negative’) may not be known for few more years or another generation 🤔 The impact on #IMIDs ..


Patients with #IMIDs had suboptimal rates of vaccination against #pneumococcal infections, despite #vaccination not being associated with disease flare. brnw.ch/21wJ8xt


In the 8 years since the discovery that Celgene’s #IMiDs degrade oncogenic transcription factors by “gluing” them to E3 ubiquitin #ligases, over a dozen #biotechs have developed molecular glue degraders. See where this field is headed > (FREE with reg) ow.ly/X4l250Mkkoy

BioCentury's tweet image. In the 8 years since the discovery that Celgene’s #IMiDs degrade oncogenic transcription factors by “gluing” them to E3 ubiquitin #ligases, over a dozen #biotechs have  developed molecular glue degraders. See where this field is headed > (FREE with reg) ow.ly/X4l250Mkkoy

The collaboration between CITF-funded researchers Drs. Vinod Chandran, @Tania_WattsUofT @gingraslab1 @UofT and others demonstrate that booster doses sustain and broaden immune responses to SARS-CoV-2 in adults with #IMIDs. ow.ly/zPBc50P5vRu

COVIDimmunityTF's tweet image. The collaboration between CITF-funded researchers Drs. Vinod Chandran, @Tania_WattsUofT @gingraslab1 @UofT and others demonstrate that booster doses sustain and broaden immune responses to SARS-CoV-2 in adults with #IMIDs.

ow.ly/zPBc50P5vRu

👩‍🔬 Meet the people behind #DocTISProject! 🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses. 🔎 doctis.eu/yolanda-guille… #IMID #IMIDs #EUResearch

DoctisEU's tweet image. 👩‍🔬 Meet the people behind #DocTISProject!

🔬 In our first young researchers interview, Yolanda Guillén (@IMIDomics) shares how advanced molecular and computational technologies help better understand patient responses.

🔎 doctis.eu/yolanda-guille…

#IMID #IMIDs #EUResearch

🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026. 🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies. 🌐 doctis.eu #IMID

DoctisEU's tweet image. 🧬 The #DocTISProject held its final Scientific Advisory Board meeting as we move towards completion in June 2026.

🙏 We thank the Board for their continuous guidance and support, helping advance progress in #IMIDs and #AutoimmuneTherapies.

🌐 doctis.eu

#IMID

🧬 What is #DocTISProject? 🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way. 🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments. 🔎 Learn more: doctis.eu #IMIDResearch

DoctisEU's tweet image. 🧬 What is #DocTISProject?

🩺 #IMIDs affect millions worldwide, but not all patients respond in the same way.

🔬 DocTIS combines clinical and molecular data with systems biology to advance more personalised treatments.

🔎 Learn more: doctis.eu

#IMIDResearch

En esta serie exclusiva de dos videos exploramos cómo herramientas como #ChatGPT están impactando la investigación, el diagnóstico y el abordaje de las #IMIDs, y analizamos las tecnologías emergentes que están redefiniendo el cuidado de la salud. #IAenSalud #InnovaciónMédica

GebroHealthTalk's tweet image. En esta serie exclusiva de dos videos exploramos cómo herramientas como #ChatGPT están impactando la investigación, el diagnóstico y el abordaje de las #IMIDs, y analizamos las tecnologías emergentes que están redefiniendo el cuidado de la salud.
#IAenSalud #InnovaciónMédica

💊 Advancing combination therapies for #IMIDs requires robust molecular data and strong clinical–research integration. 📢 Dr @hoheyn (@cnag_eu) presented Work Package 4 at the #DocTISProject webinar, focusing on molecular data generation from IMID Biobank patients. #IMID


The study led by @cnag_eu and published in @NatureMedicine, which uses data from the #DocTISProject and maps cellular inflammation at an unprecedented scale, has been featured on one of Spain’s main national TV channels. More info:👉 doctis.eu/cellular-infla… #SingleCell #IMIDs

🙌¡Nuestro atlas de la inflamación, de nuevo en TV! Un grupo de investigadores de CNAG publican el 1º atlas celular de la inflamación, que ha servido para desarrollar una herramienta IA para mejorar el diagnóstico de pacientes 📺Fuente: @A3Noticias 🔗cnag.eu/news/first-cel…



🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition #IMIDs #rheumat #gastro #ophthalm #derm link.springer.com/article/10.118…

BMCMedicine's tweet image. 🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition

#IMIDs #rheumat #gastro #ophthalm #derm

link.springer.com/article/10.118…

💊 Patient selection and characterisation are key to research on combination therapies for #IMIDs. 📢 During a #DocTISProject webinar, Dr Maria López Lasanta from H@vallhebron hospital presented the clinical features of #IMID-Biobank patients within WP3 (Patient Selection).


Hence we do need ‘Partnership in Prevention ‘ Why this approach ✅ Shared risk factors for #IMIDs including #IBD and non communicable diseases ✅ Use existing frameworks in prevention 📌 Infrastructure 📌 Regulations


🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results. 🔗 doctis.eu/doctis-six-mon… #immunemediated #IMID #AutoimmuneTherapies #IMIDResearch

DoctisEU's tweet image. 🔬 #DocTISProject has been granted a six-month extension by @EU_Commission to complete its clinical trial in #IMIDs, ensuring robust patient follow-up and high-quality final results.

🔗 doctis.eu/doctis-six-mon…

#immunemediated #IMID #AutoimmuneTherapies #IMIDResearch

The collaboration between CITF-funded researchers Drs. Vinod Chandran, @Tania_WattsUofT @gingraslab1 @UofT and others demonstrate that booster doses sustain and broaden immune responses to SARS-CoV-2 in adults with #IMIDs. ow.ly/zPBc50P5vRu

COVIDimmunityTF's tweet image. The collaboration between CITF-funded researchers Drs. Vinod Chandran, @Tania_WattsUofT @gingraslab1 @UofT and others demonstrate that booster doses sustain and broaden immune responses to SARS-CoV-2 in adults with #IMIDs.

ow.ly/zPBc50P5vRu

Tras el testimonio de Francisco cerramos la mesa de #IMIDs con reflexiones de ponentes y asistentes en torno a la atención multidisciplinar tanto a #pacientes como a #cuidadores apostando por la humanización #lazaretofh23

farupeib's tweet image. Tras el testimonio de Francisco cerramos la mesa de #IMIDs con reflexiones de ponentes y asistentes en torno a la atención multidisciplinar tanto a #pacientes como a #cuidadores apostando por la humanización  

#lazaretofh23
farupeib's tweet image. Tras el testimonio de Francisco cerramos la mesa de #IMIDs con reflexiones de ponentes y asistentes en torno a la atención multidisciplinar tanto a #pacientes como a #cuidadores apostando por la humanización  

#lazaretofh23
farupeib's tweet image. Tras el testimonio de Francisco cerramos la mesa de #IMIDs con reflexiones de ponentes y asistentes en torno a la atención multidisciplinar tanto a #pacientes como a #cuidadores apostando por la humanización  

#lazaretofh23
farupeib's tweet image. Tras el testimonio de Francisco cerramos la mesa de #IMIDs con reflexiones de ponentes y asistentes en torno a la atención multidisciplinar tanto a #pacientes como a #cuidadores apostando por la humanización  

#lazaretofh23

more strategic collabs, agreements ~#ConduitPharmaceuticals, @getclinconnect unite on cocrystal dev program ~#MIDomics enters license, collab with @UniBarcelona to advance #IMIDs treatments ~@coeptistx expands license agreement with @PittTweet

MedTechNow_'s tweet image. more strategic collabs, agreements

~#ConduitPharmaceuticals, @getclinconnect unite on cocrystal dev program 

~#MIDomics enters license, collab with @UniBarcelona to advance #IMIDs treatments  

~@coeptistx expands license agreement with @PittTweet

In the 8 years since the discovery that Celgene’s #IMiDs degrade oncogenic transcription factors by “gluing” them to E3 ubiquitin #ligases, over a dozen #biotechs have developed molecular glue degraders. See where this field is headed > (FREE with reg) ow.ly/X4l250Mkkoy

BioCentury's tweet image. In the 8 years since the discovery that Celgene’s #IMiDs degrade oncogenic transcription factors by “gluing” them to E3 ubiquitin #ligases, over a dozen #biotechs have  developed molecular glue degraders. See where this field is headed > (FREE with reg) ow.ly/X4l250Mkkoy

#OctoberIssue | Targeting inflammatory mechanisms of cardiovascular pathology in rheumatic immune-mediated inflammatory diseases (#IMIDs) and considerations for the diagnosis and management of cardiovascular involvement across rheumatic #IMIDs. bit.ly/3XWK9q7

NatRevRheumatol's tweet image. #OctoberIssue |  Targeting inflammatory mechanisms of cardiovascular pathology in rheumatic immune-mediated inflammatory diseases (#IMIDs) and  considerations for the diagnosis and management of cardiovascular involvement across rheumatic #IMIDs. 

bit.ly/3XWK9q7

With over 27,000 views, this special issue presents recent findings using omics technologies to uncover crucial molecular mechanisms underlying chronic immune-mediated inflammatory diseases (IMIDs). Access the free reprint: brnw.ch/21wE71g #mdpi #openaccess #IMIDs

MDPIOpenAccess's tweet image. With over 27,000 views, this special issue presents recent findings using omics technologies to uncover crucial molecular mechanisms underlying chronic immune-mediated inflammatory diseases (IMIDs).

Access the free reprint: brnw.ch/21wE71g

#mdpi #openaccess #IMIDs

🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition #IMIDs #rheumat #gastro #ophthalm #derm link.springer.com/article/10.118…

BMCMedicine's tweet image. 🧑‍⚕️#Debate recommends cross-speciality collaborative care in complex immune-mediated inflammatory diseases - treating the person living with the condition

#IMIDs #rheumat #gastro #ophthalm #derm

link.springer.com/article/10.118…

🆕steps in the field of Immune-Mediated Inflammatory Diseases (#IMIDs) #research 💉As part of @DoctisEU, the EU-funded initiative to improve lives of IMIDs patients, #CNAG has participated in the last assemblies 🎯Challenges: data security, standardization & resource allocation

cnag_eu's tweet image. 🆕steps in the field of Immune-Mediated Inflammatory Diseases (#IMIDs) #research

💉As part of @DoctisEU, the EU-funded initiative to improve lives of IMIDs patients, #CNAG has participated in the last assemblies

🎯Challenges: data security, standardization & resource allocation
cnag_eu's tweet image. 🆕steps in the field of Immune-Mediated Inflammatory Diseases (#IMIDs) #research

💉As part of @DoctisEU, the EU-funded initiative to improve lives of IMIDs patients, #CNAG has participated in the last assemblies

🎯Challenges: data security, standardization & resource allocation

Un placer haber participado a esta nueva edición y debatir sobre el papel de los #IMiDs y los moduladores de #cereblon en el manejo terapéutico de las neoplasias linfoides. Agradecidos a @dvalcarcel por la invitación y @roue_s @CarrerasIJC por el soporte.

gaelroueBCN's tweet image. Un placer haber participado a esta nueva edición y debatir sobre el papel de los #IMiDs y los moduladores de #cereblon en el manejo terapéutico de las neoplasias linfoides. Agradecidos a @dvalcarcel por la invitación y @roue_s @CarrerasIJC por el soporte.

Hoy parte del #equipoGTEII ha participado en @farupeib : En el bloque de IMIDs con @nuriacmart @NuriaRudi, Marta Bello y @antonia_maestre y en el bloque de Humanización con @ana_alvarezd y @kino_56 #lazaretofh24 #IMIDs #humanizacion

gteii_sefh's tweet image. Hoy parte del #equipoGTEII ha participado en @farupeib :

En el bloque de IMIDs con @nuriacmart @NuriaRudi, Marta Bello y @antonia_maestre 

y en el bloque de Humanización con @ana_alvarezd y @kino_56 

#lazaretofh24

#IMIDs #humanizacion
gteii_sefh's tweet image. Hoy parte del #equipoGTEII ha participado en @farupeib :

En el bloque de IMIDs con @nuriacmart @NuriaRudi, Marta Bello y @antonia_maestre 

y en el bloque de Humanización con @ana_alvarezd y @kino_56 

#lazaretofh24

#IMIDs #humanizacion
gteii_sefh's tweet image. Hoy parte del #equipoGTEII ha participado en @farupeib :

En el bloque de IMIDs con @nuriacmart @NuriaRudi, Marta Bello y @antonia_maestre 

y en el bloque de Humanización con @ana_alvarezd y @kino_56 

#lazaretofh24

#IMIDs #humanizacion

📱 ‘@biogen lanza la app 'Care+' para pacientes con enfermedades inflamatorias inmunomediadas.’ . ℹ️ bit.ly/3XcMWrC @DiarioSigloXXI . 📷: @NordWoodThemes #careplus #IMIDs #crohn #colitisulcerosa #EII @VitalFundazioa @Araba @vitoriagasteiz @ACCU_Espana @GETEII

AccuAlava's tweet image. 📱 ‘@biogen lanza la app 'Care+' para pacientes con enfermedades inflamatorias inmunomediadas.’ 
.
ℹ️  bit.ly/3XcMWrC  @DiarioSigloXXI
.
📷:  @NordWoodThemes #careplus #IMIDs #crohn #colitisulcerosa #EII @VitalFundazioa @Araba @vitoriagasteiz @ACCU_Espana @GETEII

#multidisciplinar23 El Dr. Menchén habla desde el punto de vista del digestólogo. ¿Qué determinantes genéticos influyen en las #IMIDs? ⏺️Sistema inmune innato ⏺️Autofagia ⏺️Activación, proliferación y supervivencia de linfocitos T ⏺️Barrera intestinal

SEReumatologia's tweet image. #multidisciplinar23 El Dr. Menchén habla desde el punto de vista del digestólogo. ¿Qué determinantes genéticos influyen en las #IMIDs?
⏺️Sistema inmune innato
⏺️Autofagia
⏺️Activación, proliferación y supervivencia de linfocitos T
⏺️Barrera intestinal

Very interesting comments from the Swedish agency #myeloma #cancer #imids

Usbourne161644's tweet image. Very interesting comments from the Swedish agency #myeloma #cancer #imids

🐦 📢 El próximo 10 de octubre participaré en la reunión “Nuevos Horizontes en IMIDs: Enfoque 360º” en Barcelona. Presentaré la ponencia “Mejorando el seguimiento del paciente”, dentro de la visión del farmacéutico. #IMIDs #FarmaciaHospitalaria #AtenciónFarmacéutica #Salud

bielmercadal1's tweet image. 🐦 📢 El próximo 10 de octubre participaré en la reunión “Nuevos Horizontes en IMIDs: Enfoque 360º” en Barcelona.
Presentaré la ponencia “Mejorando el seguimiento del paciente”, dentro de la visión del farmacéutico.

#IMIDs #FarmaciaHospitalaria #AtenciónFarmacéutica #Salud

Nuevos horizontes en #imids enfoque 360. Excelente encuentro en el que se ha demostrado la gran sinergia y trabajo colaborativo entre Derma, Farmacia Hospitalaria , Digestivo y Reuma. Debate espléndido y constructivo de los asistentes. #imids #prom #prem #valuebasedhealthcare

bielmercadal1's tweet image. Nuevos horizontes en #imids enfoque 360.
Excelente encuentro en el que se ha demostrado la gran sinergia y trabajo colaborativo entre Derma,  Farmacia Hospitalaria , Digestivo y Reuma.
Debate espléndido y constructivo de los asistentes.
#imids #prom #prem #valuebasedhealthcare

#multidisciplinar23 Dr. Queiro: Las enfermedades inflamatorias inmunomediadas #IMIDs no son raras, con una prevalencia del 6% en el mundo occidental ✔️Enfermedades con alto poder discapacitante ✔️Potencial de daño estructural y daño orgánico ✔️Es común la concurrencia de 2 o más

SEReumatologia's tweet image. #multidisciplinar23 Dr. Queiro: Las enfermedades inflamatorias inmunomediadas #IMIDs no son raras, con una prevalencia del 6% en el mundo occidental
✔️Enfermedades con alto poder discapacitante
✔️Potencial de daño estructural y daño orgánico 
✔️Es común la concurrencia de 2 o más

Chai et al. observed that #UPA is effective in treating #IMIDs like RA, axSpA, PsA, CD, and UC. Read the summary here:🔗ow.ly/IWPW50WNtre

TheIMIDForum's tweet image. Chai et al. observed that #UPA is effective in treating #IMIDs like RA, axSpA, PsA, CD, and UC. 

Read the summary here:🔗ow.ly/IWPW50WNtre

Loading...

Something went wrong.


Something went wrong.